INDOCO price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- INDOCO
- MB Code
- MBEQU551
- ISIN
- INE873D01024
- BSE code
- 532612
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 475.61 Cr
- Net profit
- -23.68 Cr
- EPS
- -2.56
- YoY revenue
- +21.89%
Company documents
11 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for INDOCO
Indoco Remedies' March quarter loss narrowed to ₹22 crore from ₹40 crore, revenue rose 22% to ₹476 crore and EBITDA turned positive at ₹5…
EPS -3.01 vs est. -3.84
Missed estimates by 21.57%
EPS -3.20 vs est. 0.40
Missed estimates by 892.08%
Indoco Remedies shares rose over 8.5% on January 30, 2026, following USFDA approval for its Lacosamide Oral Solution, a generic of Vimpat…
EPS -1.07 vs est. -0.91
Beat estimates by 17.71%
Dividend of ₹0.20 per share
Ex-date corporate action
Price returns
Historical performance
Technicals
Indicator consensus